Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 4
1998 6
1999 13
2000 9
2001 12
2002 18
2003 23
2004 19
2005 19
2006 20
2007 10
2008 14
2009 16
2010 6
2011 8
2012 12
2013 11
2014 11
2015 7
2016 13
2017 4
2019 3
2020 4
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

242 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
Mahatme MS, Dakhale GN, Tadke K, Hiware SK, Dudhgaonkar SD, Wankhede S. Mahatme MS, et al. Indian J Pharmacol. 2016 Nov-Dec;48(6):649-653. doi: 10.4103/0253-7613.194854. Indian J Pharmacol. 2016. PMID: 28066101 Free PMC article. Clinical Trial.

The mean change of TNSS, i.e., 9.46 was significant (P < 0.05) in montelukast-fexofenadine group. The cost-effectiveness ratio was less in montelukast-levocetirizine group than in montelukast-fexofenadine group. CONCLUSION: The decrease in TNSS was more in montel

The mean change of TNSS, i.e., 9.46 was significant (P < 0.05) in montelukast-fexofenadine group. The cost-effectiveness ratio was

The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.
Akamine Y, Miura M, Komori H, Tamai I, Ieiri I, Yasui-Furukori N, Uno T. Akamine Y, et al. Drug Metab Pharmacokinet. 2015 Oct;30(5):352-7. doi: 10.1016/j.dmpk.2015.06.005. Epub 2015 Jun 26. Drug Metab Pharmacokinet. 2015. PMID: 26213156 Clinical Trial.
Therefore, in this study, we aimed to investigate whether and to what extent GFJ ingestion affected the pharmacokinetics of fexofenadine enantiomers in healthy subjects. In a randomized, two-phase, open-label, crossover study, 14 subjects received 60 mg of racemic fexof
Therefore, in this study, we aimed to investigate whether and to what extent GFJ ingestion affected the pharmacokinetics of fexofenadine
Bioavailability assessment of fexofenadine and montelukast in a fixed-dose combination tablet versus the components administered simultaneously.
Everardo PG, Magdalena GS, Maria Elena GP, Vanessa CM, Gabriela SC. Everardo PG, et al. Allergol Immunopathol (Madr). 2021 Jul 1;49(4):15-25. doi: 10.15586/aei.v49i4.89. eCollection 2021. Allergol Immunopathol (Madr). 2021. PMID: 34224214 Clinical Trial.
MATERIALS AND METHODS: An open, randomized, 22 crossover study was performed in 78 healthy volunteers. Fexofenadine-montelukast tablets containing 120 mg and 10 mg, respectively, were used as the test treatment, and 120 mg fexofenadine tablets and 10 mg montelukast …
MATERIALS AND METHODS: An open, randomized, 22 crossover study was performed in 78 healthy volunteers. Fexofenadine-montelukast table …
A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance.
Theunissen EL, Jonkman LM, Kuypers KP, Ramaekers JG. Theunissen EL, et al. J Psychopharmacol. 2006 Jul;20(4):496-505. doi: 10.1177/0269881105058362. Epub 2005 Sep 20. J Psychopharmacol. 2006. PMID: 16174671 Clinical Trial.
However, some studies suggested mild stimulant effects in the case of fexofenadine. The goals of this study are to examine whether fexofenadine possesses stimulating properties and to determine whether such stimulating effects are related to workload. ...Performance …
However, some studies suggested mild stimulant effects in the case of fexofenadine. The goals of this study are to examine whether …
The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
Tateishi T, Miura M, Suzuki T, Uno T. Tateishi T, et al. Br J Clin Pharmacol. 2008 May;65(5):693-700. doi: 10.1111/j.1365-2125.2008.03116.x. Epub 2008 Feb 20. Br J Clin Pharmacol. 2008. PMID: 18294330 Free PMC article. Clinical Trial.
Twelve healthy volunteers received either itraconazole 200 mg or matched placebo in a randomized fashion with a single oral dose of fexofenadine 60 mg simultaneously. The plasma concentrations and the amount of urinary excretion (Ae) of fexofenadine enantiomers were …
Twelve healthy volunteers received either itraconazole 200 mg or matched placebo in a randomized fashion with a single oral dose of fexof
Comparative Efficacy of Fexofenadine Versus Levocetrizine Versus Desloratadine via 1% Histamine Wheal Suppression Test.
Kc S , Aryal A , Adhikary M , Karn D . Kc S , et al. Kathmandu Univ Med J (KUMJ). 2020 Jan.-Mar;18(69):19-22. Kathmandu Univ Med J (KUMJ). 2020. PMID: 33582682 Clinical Trial.
Objective To compare the efficacy of levocetrizine versus fexofenadine versus desloratadine in suppressing histamine induced wheals in adults. ...However by 2 and 4 hours all three antihistamines; fexofenadine, levocetirizine and desloratadine showed significant sup …
Objective To compare the efficacy of levocetrizine versus fexofenadine versus desloratadine in suppressing histamine induced wheals i …
Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers.
Akamine Y, Miura M, Yasui-Furukori N, Kojima M, Uno T. Akamine Y, et al. Br J Clin Pharmacol. 2012 Mar;73(3):478-81. doi: 10.1111/j.1365-2125.2011.04106.x. Br J Clin Pharmacol. 2012. PMID: 21950458 Free PMC article. Clinical Trial.
AIM: This aim of this study was to characterize the impact of the P-glycoprotein (P-gp) inducer, carbamazepine, on fexofenadine enantiomer pharmacokinetics. METHODS: Twelve healthy volunteers initially received a 60mg dose of fexofenadine alone. ...The P-gp inducer …
AIM: This aim of this study was to characterize the impact of the P-glycoprotein (P-gp) inducer, carbamazepine, on fexofenadine enant …
Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis.
Shintani T, Ohata C, Koga H, Ohyama B, Hamada T, Nakama T, Furumura M, Tsuruta D, Ishii N, Hashimoto T. Shintani T, et al. Dermatol Ther. 2014 May-Jun;27(3):135-9. doi: 10.1111/dth.12094. Epub 2013 Sep 17. Dermatol Ther. 2014. PMID: 24102897 Clinical Trial.
All patients received 10 mg montelukast once a day and 240 mg fexofenadine twice a day for 4 weeks in addition to other medications they had been taking. ...Thus, 11 of 15 cases (73.3%) improved by combination therapy of fexofenadine and montelukast, in which nine c …
All patients received 10 mg montelukast once a day and 240 mg fexofenadine twice a day for 4 weeks in addition to other medications t …
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers.
Misaka S, Ono Y, Taudte RV, Hoier E, Ogata H, Ono T, König J, Watanabe H, Fromm MF, Shimomura K. Misaka S, et al. Clin Pharmacol Ther. 2022 Sep;112(3):627-634. doi: 10.1002/cpt.2682. Epub 2022 Jun 29. Clin Pharmacol Ther. 2022. PMID: 35678032 Clinical Trial.
The purpose of this study was to investigate whether pharmacokinetics of fexofenadine and pseudoephedrine are affected by catechins, major GT components. ...There were no differences in time to maximum plasma concentration and the elimination half-life of fexofenadine
The purpose of this study was to investigate whether pharmacokinetics of fexofenadine and pseudoephedrine are affected by catechins, …
Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites.
Srinivas NR. Srinivas NR. Drug Dev Ind Pharm. 2016;42(6):945-57. doi: 10.3109/03639045.2015.1096278. Epub 2015 Oct 15. Drug Dev Ind Pharm. 2016. PMID: 26467209 Clinical Trial.
METHODS: A simple unweighted linear regression model was developed to describe the relationship between Cmax versus AUC for fexofenadine, losartan, EXP3174, itraconazole and hydroxyitraconazole. ...The r values for observed versus predicted AUC were 0.9653 (n = 145), 0.834 …
METHODS: A simple unweighted linear regression model was developed to describe the relationship between Cmax versus AUC for fexofenadine
242 results